Chetan of 42 yrs old man came with complaints of fleshy mass in left eye associated with pain and pricking sensation from 4-5months with vision right eye -6/6 and left eye -6/9 improving to 6/6 .with no co morbidities and no past medical history.other ocular findings are normal . Asoct and fnac showed ossn with no deeper involvement and mod dysplasia leading to provisional diagnosis as right eye gelatinous oculo surface squamous neoplasia .treatment included to left eye interferon alpha 2b, 1 percent 5 flurouracil eyedrops (given on and off)and artificial tear drops and further follow up done and shown good results . Make this in to poster presentation for an ophthalmologist in 100 characters
Professional ophthalmology case report poster for a medical conference. Title: "Gelatinous Ocular Surface Squamous Neoplasia (OSSN): A Case Report". Clean academic layout with white background and teal/navy blue color scheme. Sections clearly divided: PATIENT: 42-year-old male | Chetan | No comorbidities CHIEF COMPLAINT: Fleshy mass in left eye with pain and pricking sensation x 4-5 months VISUAL ACUITY: OD: 6/6 | OS: 6/9 improving to 6/6 CLINICAL FINDINGS: Elevated fleshy gelatinous pinkish-red limbal mass on nasal bulbar conjunctiva with corneal encroachment | Significant conjunctival injection | Periocular skin: erythematous papules and plaques INVESTIGATIONS: AS-OCT: No deeper stromal involvement | FNAC: Moderate dysplasia | Diagnosis: Gelatinous Ocular Surface Squamous Neoplasia (OSSN) - Left Eye TREATMENT: Interferon alpha-2b eye drops (topical) | 1% 5-Fluorouracil eye drops (on-and-off regimen) | Artificial tear drops | Regular follow-up OUTCOME: Good clinical response on follow-up Include a small placeholder box labeled "Clinical Photo" on right side. Footer: Ophthalmology Department | Case Report 2026. Use clear medical typography, numbered sections, minimal icons.

| Section | Details |
|---|---|
| Patient | 42M, no comorbidities, no past medical history |
| Complaint | Fleshy mass, pain & pricking sensation in Left Eye x 4-5 months |
| VA | OD: 6/6 / OS: 6/9 (pinhole 6/6) |
| Clinical | Gelatinous, elevated nasal limbal mass with conjunctival injection; periocular papular skin changes |
| Investigations | AS-OCT: no deeper involvement; FNAC: moderate dysplasia |
| Diagnosis | Gelatinous Ocular Surface Squamous Neoplasia (OSSN) - Left Eye |
| Treatment | Topical IFN-alpha-2b + 1% 5-FU (on-off) + artificial tears |
| Outcome | Good response on follow-up |
What kind off carcinoma can this be
"Sebaceous carcinoma originates from sebaceous glands either in the tarsal plate (meibomian gland) or associated with eyelashes (glands of Zeis) and is capable of producing widespread metastasis resulting in death." - Goldman-Cecil Medicine
"Squamous cell carcinoma can metastasize, most often to regional lymph nodes. It also can invade the orbit and cavernous sinus via perineural spread from untreated lesions on the eyelids." - Goldman-Cecil Medicine
| Feature in Image | SGC | SCC | BCC |
|---|---|---|---|
| Upper eyelid location | ✅ Classic | Possible | Uncommon |
| Fungating, necrotic mass | ✅ Advanced SGC | ✅ Classic | Only if neglected |
| Yellow-white lipid-rich slough | ✅ | Less specific | ✗ |
| Orbital invasion | ✅ | ✅ | Medial canthus only |
| Metastatic potential | ✅ High | ✅ Moderate | ✗ Rare |
Make one fake poster presentation for ophthalmologist
Squamous cell carcinoma
Professional ophthalmology medical conference poster presentation. Title: "Advanced Squamous Cell Carcinoma of the Upper Eyelid with Orbital Extension: A Case Report". Academic layout, navy blue and white color scheme with gold accent headers. Portrait orientation. Clearly divided sections with clean medical typography: TOP HEADER BAND (navy blue): Institution: Department of Ophthalmology, Regional Eye Institute | Conference: AIOC 2026 | Authors: Dr. R. Sharma, Dr. P. Mehta, Dr. S. Nair SECTION 1 - INTRODUCTION (gold header): Squamous Cell Carcinoma (SCC) of the eyelid is a rare but aggressive malignancy arising from surface squamous epithelium. UV radiation is the primary risk factor. Advanced neglected cases may present with orbital invasion, perineural spread, and regional lymph node metastasis. Early recognition and biopsy are essential. SECTION 2 - CASE PRESENTATION (gold header): • 58-year-old male farmer, outdoor worker, no comorbidities • Complaints: Rapidly growing mass left upper eyelid x 8 months • Associated: Pain, watering, restricted eye opening • VA: OD 6/6 | OS: Hand movements only • Clinical: 3 cm fungating ulceroproliferative mass, upper eyelid, rolled everted margins, central necrotic crater, orbital extension, proptosis • Lymph nodes: Left preauricular node palpable, 1.5 cm, firm SECTION 3 - INVESTIGATIONS (gold header): • Incisional Biopsy: Moderately differentiated SCC with keratin pearls, perineural invasion • CT Orbit: Mass involving upper lid, preseptal and post-septal extension, no bony destruction • CT Chest/Abdomen: No distant metastasis • HIV, Immunosuppression workup: Negative SECTION 4 - MANAGEMENT (gold header): • Multidisciplinary team: Ophthalmology + Oncology + Radiation Oncology • Surgical: Left orbital exenteration with safe margins • Adjuvant: External beam radiotherapy 60 Gy / 30 fractions • Sentinel node biopsy: Negative for metastasis • Follow-up: 12 months - No local recurrence SECTION 5 - DISCUSSION (gold header): SCC of the eyelid accounts for 5-10% of eyelid malignancies. Neglected tumors risk orbital invasion and cavernous sinus spread via perineural route. Mohs micrographic surgery preferred for early lesions. Exenteration reserved for advanced orbital involvement. Adjuvant radiotherapy reduces recurrence rates. SECTION 6 - CONCLUSION (gold header): Advanced eyelid SCC requires prompt histopathological diagnosis and aggressive multimodal treatment. Awareness, early detection, and sun protection remain key preventive strategies. Two image placeholder boxes labeled "Clinical Photo" and "Histopathology (H&E)" side by side in center. Bottom footer: "Corresponding Author: dr.rsharma@reih.org | Poster No. OP-47"

Create a downloadable PowerPoint version of this poster
ls -la /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace/…
mkdir -p /home/daytona/workspace/scc-poster && node -e "require('pptxgenjs'); co…
~/scc-poster/create_poster.js
const pptxgen = require("pptxgenjs");
const pres = new pptxgen();
// Use LAYOUT_WIDE for poster-style (13.3" x 7.5")
pres.layout = "LAYOUT_WIDE";
pres.title = "SCC Eyelid - Case Report Poster";
pres.author = "Dr. R. Sharma";
// ── COLOR PALETTE ──────────────────────────────────────
const NAVY = "0D2B55";
const GOLD = "B8860B";
const GOLD_LT = "F0C040";
const WHITE = "FFFFFF";
const LIGHT = "E8EFF8";
const DARK_TXT= "1A1A2E";
const GRAY = "6B7280";
const RED_ACC = "C0392B";
// ── SLIDE 1: POSTER (single slide, landscape) ──────────
const slide = pres.addSlide();
// ── BACKGROUND ──
slide.addShape(pres.shapes.RECTANGLE, {
x: 0, y: 0, w: 13.3, h: 7.5,
fill: { color: "F4F6FB" }, line: { color: "F4F6FB" }
});
// ── TOP HEADER BAND ──
slide.addShape(pres.shapes.RECTANGLE, {
x: 0, y: 0, w: 13.3, h: 1.1,
fill: { color: NAVY }, line: { color: NAVY }
});
// Gold accent bar under header
slide.addShape(pres.shapes.RECTANGLE, {
x: 0, y: 1.1, w: 13.3, h: 0.06,
fill: { color: GOLD_LT }, line: { color: GOLD_LT }
});
// Header: Main title
slide.addText("Advanced Squamous Cell Carcinoma of the Upper Eyelid with Orbital Extension", {
x: 0.3, y: 0.05, w: 12.7, h: 0.55,
fontSize: 22, bold: true, color: WHITE, fontFace: "Calibri",
align: "center", valign: "middle", margin: 0
});
// Header: subtitle / authors
slide.addText("A Case Report | Dr. R. Sharma · Dr. P. Mehta · Dr. S. Nair | Department of Ophthalmology, Regional Eye Institute", {
x: 0.3, y: 0.62, w: 9, h: 0.38,
fontSize: 9.5, color: GOLD_LT, fontFace: "Calibri",
align: "left", valign: "middle", margin: 0
});
// Header: conference badge (right)
slide.addShape(pres.shapes.ROUNDED_RECTANGLE, {
x: 11.0, y: 0.15, w: 2.0, h: 0.75,
fill: { color: GOLD }, line: { color: GOLD }, rectRadius: 0.08
});
slide.addText([
{ text: "AIOC 2026", options: { bold: true, breakLine: true } },
{ text: "Poster OP-47" }
], {
x: 11.0, y: 0.15, w: 2.0, h: 0.75,
fontSize: 9, color: WHITE, fontFace: "Calibri",
align: "center", valign: "middle"
});
// ── LAYOUT: 3 columns below header ──
// Col 1: x=0.15, w=3.9
// Col 2: x=4.25, w=4.9 (center, wider)
// Col 3: x=9.3, w=3.85
const colY = 1.25;
const colH = 5.85;
const boxR = 0.1;
// Section helper: draws a card with colored header bar
function addCard(slide, pres, x, y, w, h, titleText, titleColor) {
// Card background
slide.addShape(pres.shapes.ROUNDED_RECTANGLE, {
x, y, w, h,
fill: { color: WHITE },
line: { color: "D0D8E8", width: 0.75 },
rectRadius: boxR,
shadow: { type: "outer", color: "000000", blur: 6, offset: 2, angle: 135, opacity: 0.1 }
});
// Title bar
slide.addShape(pres.shapes.RECTANGLE, {
x: x + 0.01, y: y + 0.01, w: w - 0.02, h: 0.32,
fill: { color: titleColor || NAVY }, line: { color: titleColor || NAVY }
});
// Section title text
slide.addText(titleText, {
x: x + 0.08, y: y + 0.01, w: w - 0.16, h: 0.32,
fontSize: 10, bold: true, color: WHITE, fontFace: "Calibri",
align: "left", valign: "middle", margin: 0
});
}
// ── COLUMN 1 ──────────────────────────────────────────
const c1x = 0.15;
const c1w = 3.9;
// Card 1: Introduction
addCard(slide, pres, c1x, colY, c1w, 2.05, "INTRODUCTION", NAVY);
slide.addText([
{ text: "Squamous Cell Carcinoma (SCC) of the eyelid is a rare but aggressive malignancy arising from the surface squamous epithelium.\n\n", options: { breakLine: false } },
{ text: "UV radiation", options: { bold: true } },
{ text: " is the primary risk factor. Advanced neglected cases may present with orbital invasion, perineural spread, and regional lymph node metastasis.\n\n", options: { breakLine: false } },
{ text: "Incidence:", options: { bold: true } },
{ text: " SCC accounts for 5–10% of all eyelid malignancies. Prompt histopathological diagnosis and multimodal management are critical for a good outcome." }
], {
x: c1x + 0.1, y: colY + 0.38, w: c1w - 0.2, h: 1.6,
fontSize: 8.5, color: DARK_TXT, fontFace: "Calibri",
align: "left", valign: "top", margin: 0
});
// Card 2: Investigations
addCard(slide, pres, c1x, colY + 2.15, c1w, 2.2, "INVESTIGATIONS", "1A5276");
const invItems = [
{ text: "Incisional Biopsy:", bold: true, val: " Moderately differentiated SCC; keratin pearls, perineural invasion confirmed on H&E." },
{ text: "CT Orbit:", bold: true, val: " 3 cm mass, upper lid, preseptal + postseptal extension. No bony destruction." },
{ text: "CT Chest/Abdomen:", bold: true, val: " No distant metastasis detected." },
{ text: "Lymph Node FNAC:", bold: true, val: " Left preauricular node - reactive changes only." },
{ text: "Immunocompromise workup:", bold: true, val: " HIV negative. No immunosuppression." }
];
const invRich = [];
invItems.forEach((item, i) => {
invRich.push({ text: item.text, options: { bold: true, color: NAVY } });
invRich.push({ text: item.val + (i < invItems.length - 1 ? "\n" : ""), options: { color: DARK_TXT } });
});
slide.addText(invRich, {
x: c1x + 0.1, y: colY + 2.15 + 0.38, w: c1w - 0.2, h: 1.76,
fontSize: 8.2, fontFace: "Calibri", align: "left", valign: "top", margin: 0
});
// Card 3: Conclusion
addCard(slide, pres, c1x, colY + 4.45, c1w, 1.35, "CONCLUSION", RED_ACC);
slide.addText([
{ text: "Advanced eyelid SCC requires ", options: { color: DARK_TXT } },
{ text: "prompt biopsy", options: { bold: true, color: RED_ACC } },
{ text: " and ", options: { color: DARK_TXT } },
{ text: "aggressive multimodal treatment.\n\n", options: { bold: true, color: RED_ACC } },
{ text: "Awareness, early referral to ophthalmology, and ", options: { color: DARK_TXT } },
{ text: "sun protection", options: { bold: true, color: DARK_TXT } },
{ text: " remain the cornerstones of prevention. Orbital exenteration, though disfiguring, may be life-saving in advanced cases.", options: { color: DARK_TXT } }
], {
x: c1x + 0.1, y: colY + 4.45 + 0.38, w: c1w - 0.2, h: 0.9,
fontSize: 8.2, fontFace: "Calibri", align: "left", valign: "top", margin: 0
});
// ── COLUMN 2 (CENTER) ──────────────────────────────────
const c2x = 4.25;
const c2w = 4.9;
// Card: Case Presentation
addCard(slide, pres, c2x, colY, c2w, 2.85, "CASE PRESENTATION", "145A32");
const caseItems = [
["Patient:", "58-year-old male, outdoor farmer, no comorbidities"],
["Complaint:", "Rapidly growing mass in left upper eyelid × 8 months"],
["Symptoms:", "Pain, epiphora, restricted eye opening, discharge"],
["Visual Acuity:", "OD: 6/6 | OS: Hand movements only"],
["Clinical:", "3 cm fungating ulceroproliferative mass, upper eyelid with rolled everted margins, central necrotic crater, orbital extension, proptosis"],
["Lymph Nodes:", "Left preauricular node - 1.5 cm, firm, non-tender"],
["Other Eye:", "Right eye - normal, no lesions"],
];
const caseRich = [];
caseItems.forEach((row, i) => {
caseRich.push({ text: row[0] + " ", options: { bold: true, color: "145A32" } });
caseRich.push({ text: row[1] + (i < caseItems.length - 1 ? "\n" : ""), options: { color: DARK_TXT } });
});
slide.addText(caseRich, {
x: c2x + 0.12, y: colY + 0.38, w: c2w - 0.24, h: 2.4,
fontSize: 8.4, fontFace: "Calibri", align: "left", valign: "top", margin: 0
});
// Card: Management
addCard(slide, pres, c2x, colY + 2.95, c2w, 2.85, "MANAGEMENT & OUTCOME", "6E2FA1");
const mgmtItems = [
["MDT:", "Ophthalmology + Oncology + Radiation Oncology"],
["Surgery:", "Left orbital exenteration with 5 mm safe margins"],
["Histopath:", "pT3 N0 M0 - Moderately differentiated SCC, clear margins"],
["Adjuvant RT:", "External beam radiotherapy - 60 Gy / 30 fractions over 6 weeks"],
["Sentinel Node:", "Intraoperative biopsy - Negative for metastatic disease"],
["Prosthesis:", "Ocular prosthesis fitted at 3 months post-surgery"],
["Follow-up:", "12 months - No local recurrence, no distant metastasis"],
["Outcome:", "Patient disease-free, functional, returned to daily activities"],
];
const mgmtRich = [];
mgmtItems.forEach((row, i) => {
mgmtRich.push({ text: row[0] + " ", options: { bold: true, color: "6E2FA1" } });
mgmtRich.push({ text: row[1] + (i < mgmtItems.length - 1 ? "\n" : ""), options: { color: DARK_TXT } });
});
slide.addText(mgmtRich, {
x: c2x + 0.12, y: colY + 2.95 + 0.38, w: c2w - 0.24, h: 2.4,
fontSize: 8.4, fontFace: "Calibri", align: "left", valign: "top", margin: 0
});
// ── COLUMN 3 ──────────────────────────────────────────
const c3x = 9.3;
const c3w = 3.85;
// Card: Clinical Photo placeholder
addCard(slide, pres, c3x, colY, c3w, 1.9, "CLINICAL PHOTOGRAPH", "7D6608");
slide.addShape(pres.shapes.RECTANGLE, {
x: c3x + 0.12, y: colY + 0.4, w: c3w - 0.24, h: 1.38,
fill: { color: "D5D8DC" }, line: { color: "AAB0B8", width: 0.5 }
});
slide.addText("[Insert Clinical Photo Here]", {
x: c3x + 0.12, y: colY + 0.4, w: c3w - 0.24, h: 1.38,
fontSize: 9, color: "555555", fontFace: "Calibri",
align: "center", valign: "middle", italic: true
});
// Card: Histopathology placeholder
addCard(slide, pres, c3x, colY + 2.0, c3w, 1.9, "HISTOPATHOLOGY (H&E)", "7D6608");
slide.addShape(pres.shapes.RECTANGLE, {
x: c3x + 0.12, y: colY + 2.0 + 0.4, w: c3w - 0.24, h: 1.38,
fill: { color: "D5D8DC" }, line: { color: "AAB0B8", width: 0.5 }
});
slide.addText("[Insert H&E Slide Here]\nKeratin pearls / Perineural invasion", {
x: c3x + 0.12, y: colY + 2.0 + 0.4, w: c3w - 0.24, h: 1.38,
fontSize: 8.5, color: "555555", fontFace: "Calibri",
align: "center", valign: "middle", italic: true
});
// Card: Discussion
addCard(slide, pres, c3x, colY + 4.0, c3w, 1.8, "DISCUSSION", "1A5276");
slide.addText([
{ text: "• ", options: {} },
{ text: "SCC", options: { bold: true } },
{ text: " = 5–10% of eyelid malignancies\n", options: {} },
{ text: "• Perineural spread", options: { bold: true } },
{ text: " → cavernous sinus risk if untreated\n", options: {} },
{ text: "• Mohs surgery", options: { bold: true } },
{ text: " preferred for early lesions\n", options: {} },
{ text: "• Exenteration", options: { bold: true } },
{ text: " for advanced orbital disease\n", options: {} },
{ text: "• Adjuvant RT", options: { bold: true } },
{ text: " reduces local recurrence\n", options: {} },
{ text: "• UV protection", options: { bold: true } },
{ text: " key in outdoor workers", options: {} }
], {
x: c3x + 0.1, y: colY + 4.0 + 0.38, w: c3w - 0.2, h: 1.35,
fontSize: 8.2, color: DARK_TXT, fontFace: "Calibri",
align: "left", valign: "top", margin: 0
});
// ── FOOTER BAR ──
slide.addShape(pres.shapes.RECTANGLE, {
x: 0, y: 7.2, w: 13.3, h: 0.3,
fill: { color: NAVY }, line: { color: NAVY }
});
slide.addText("Corresponding Author: dr.rsharma@reih.org | Dept. of Ophthalmology, Regional Eye Institute | Poster No. OP-47 | AIOC Annual Conference 2026", {
x: 0.2, y: 7.2, w: 12.9, h: 0.3,
fontSize: 7.5, color: GOLD_LT, fontFace: "Calibri",
align: "center", valign: "middle", margin: 0
});
// ── WRITE FILE ──
const outPath = "/home/daytona/workspace/scc-poster/SCC_Eyelid_Poster_AIOC2026.pptx";
pres.writeFile({ fileName: outPath }).then(() => {
console.log("DONE: " + outPath);
}).catch(err => {
console.error("ERROR:", err.message);
});
cd /home/daytona/workspace/scc-poster && node create_poster.js
SCC Eyelid Poster AIOC2026
Presentation · PPTX
| Column | Content |
|---|---|
| Left | Introduction, Investigations, Conclusion |
| Centre | Case Presentation, Management & Outcome |
| Right | Clinical Photo placeholder, H&E placeholder, Discussion |
Give a brief introduction about squamous cell carcinoma for an ophthalmologist
| Site | Notes |
|---|---|
| Eyelid skin | Arises from cutaneous squamous epithelium; more common on the lower eyelid and periocular skin |
| Ocular surface (conjunctiva/cornea) | Known as Ocular Surface Squamous Neoplasia (OSSN); arises at the limbus, typically nasal bulbar conjunctiva |
"Squamous cell carcinoma can metastasize, most often to regional lymph nodes. It also can invade the orbit and cavernous sinus via perineural spread from untreated lesions on the eyelids." - Goldman-Cecil Medicine
| Stage | Treatment |
|---|---|
| Early/localized eyelid SCC | Surgical excision with Mohs micrographic surgery (preferred - maximizes margin control and tissue preservation) |
| Conjunctival OSSN | Topical interferon alpha-2b or 1% 5-fluorouracil (medical treatment); surgical excision with cryotherapy to margins |
| Advanced with orbital invasion | Orbital exenteration + adjuvant radiotherapy (60 Gy / 30 fractions) |
| Non-surgical candidates | Topical imiquimod, topical/injectable interferon |
| Post-treatment | Follow-up every 6-12 months; patients with one skin malignancy are at elevated risk for further lesions |
Generate a image of this person after treatment and surgery for scc
Create a generic illustration
Medical illustration showing a generic middle-aged South Asian male patient after successful orbital exenteration surgery for advanced squamous cell carcinoma of the left upper eyelid. Post-operative appearance: the left orbital socket is well-healed with smooth skin coverage over the socket, sutured closed showing mature surgical scar lines around the left orbital rim. The patient is wearing a realistic ocular prosthesis (artificial eye) fitted in the left socket, matching the right eye in color. The right eye appears normal and healthy. The periocular skin is healed and clear, no tumor or mass visible. The patient has a calm, recovered expression. Clean clinical photograph style, neutral background, soft lighting. Educational medical illustration. No blood, no active wounds, healed post-surgical appearance.
